New proficiency testing programme launched in China

Providing Chinese biobanks and laboratories with an external quality assessment tool to verify the precision and accuracy of biospecimen testing methods

picture of

Breaking News

New proficiency testing programme launched in China

Providing Chinese biobanks and laboratories with an external quality assessment tool to verify the precision and ...

Abzena and Telix sign manufacturing and bioconjugation agreement

The agreement between the developer and manufacturer of biopharmaceuticals and the radio-pharmaceuticals specialist is ...

Plasticell leads gene therapy manufacturing consortium

UK’s innovation agency provides funding to develop advanced technologies for the manufacturing of autologous ex vivo ...

Barrier systems: taking a safety first approach to processing highly potent pharmaceuticals

To effectively protect humans and products from each other, demand for closed barrier systems such as cRABS and ...

BASF invests in carbon recycling company LanzaTech

The patented biotechnological procedure cuts carbon dioxide emissions by turning carbon monoxide and hydrogen into ...

Increasing competition in the psoriasis market

UCB, a global biopharmaceutical company, has potential to compete in the psoriasis market with Cimzia FDA approval, ...

Performance validation: HPAPI containment testing in a risk-based era

Taking a more automated approach to validation testing paves the way to capturing more repeatable and reliable data, ...

TxCell names Lonza as its CAR-Treg cellular product manufacturer

Master Service Agreement signed between Lonza Pharma & Biotech and TxCell for the manufacture of TxCell’s HLA-A2 CAR- ...

Catalent Biologics supports InterveXion on new treatment for methamphetamine users

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for ...

Overcoming cell product manufacturing challenges

Angharad Baldwin speaks to Massimiliano Cesarini, Global Sales Manager of the Isolation Technology Division at Comecer, ...

Gene transfer therapy approved for the treatment of ALL: part I

In August 2017, Novartis received FDA approval for its chimeric antigen receptor T (CAR-T) cell therapy, Kymriah, for ...

In vivo models to target respiratory diseases

Envigo’s Steve Jordan offers intuitive analysis and insights into methods of optimising in vivo efficacy studies and ...

Avacta announces successful outcome of gene delivery collaboration

Sustained production of Affimer drugs by muscle tissue in vivo could lead to major patient and commercial benefits

BIA Separations and Biomay collaborate on production and purification of large DNA plasmids

The collaboration enables high yield, high purity supercoiled plasmid DNA manufacture for therapeutic application